Muscarinic receptor control of pyramidal neuron membrane potential in the medial prefrontal cortex (mPFC) in rats

Neuroscience. 2015 Sep 10:303:474-88. doi: 10.1016/j.neuroscience.2015.07.023. Epub 2015 Jul 14.

Abstract

Damage to the cholinergic input to the prefrontal cortex has been implicated in neuropsychiatric disorders. Cholinergic endings release acetylcholine, which activates nicotinic and/or G-protein-coupled muscarinic receptors. Muscarinic receptors activate transduction systems, which control cellular effectors that regulate the membrane potential in medial prefrontal cortex (mPFC) neurons. The mechanisms responsible for the cholinergic-dependent depolarization of mPFC layer V pyramidal neurons in slices obtained from young rats were elucidated in this study. Glutamatergic and GABAergic transmission as well as tetrodotoxin (TTX)-sensitive Na(+) and voltage-dependent Ca(++) currents were eliminated. Cholinergic receptor stimulation by carbamoylcholine chloride (CCh; 100 μM) evoked depolarization (10.0 ± 1.3 mV), which was blocked by M1/M4 (pirenzepine dihydrochloride, 2 μM) and M1 (VU 0255035, 5 μM) muscarinic receptor antagonists and was not affected by a nicotinic receptor antagonist (mecamylamine hydrochloride, 10 μM). CCh-dependent depolarization was attenuated by extra- (20 μM) or intracellular (50 μM) application of an inhibitor of the βγ-subunit-dependent transduction system (gallein). It was also inhibited by intracellular application of a βγ-subunit-binding peptide (GRK2i, 10μM). mPFC pyramidal neurons express Nav1.9 channels. CCh-dependent depolarization was abolished in the presence of antibodies against Nav1.9 channels in the intracellular solution and augmented by the presence of ProTx-I toxin (100 nM) in the extracellular solution. CCh-induced depolarization was not affected by the following reagents: intracellular transduction system blockers, including U-73122 (10 μM), chelerythrine chloride (5 μM), SQ 22536 (100 μM) and H-89 (2 μM); channel blockers, including Ba(++) ions (200 μM), apamin (100 nM), flufenamic acid (200 μM), 2-APB (200 μM), SKF 96365 (50 μM), and ZD 7288 (50 μM); and a Na(+)/Ca(++) exchanger blocker, benzamil (20 μM). We conclude that muscarinic M1 receptor-dependent depolarization in mPFC pyramidal neurons is evoked by the activation of Nav1.9 channels and that the signal transduction pathway involves G-protein βγ subunits.

Keywords: Nav1.9 channels; muscarinic receptors; prefrontal cortex; pyramidal neurons; rats; βγ subunits.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amiloride / analogs & derivatives
  • Amiloride / pharmacology
  • Animals
  • Animals, Newborn
  • Apamin / pharmacology
  • Carbachol / pharmacology
  • Cholinergic Agonists / pharmacology
  • Drug Interactions
  • Ganglia, Spinal / metabolism
  • In Vitro Techniques
  • Male
  • Membrane Potentials / drug effects
  • Membrane Potentials / physiology*
  • NAV1.9 Voltage-Gated Sodium Channel / metabolism
  • Prefrontal Cortex / cytology*
  • Pyramidal Cells / drug effects
  • Pyramidal Cells / physiology*
  • Rats
  • Receptors, Muscarinic / metabolism*
  • Sodium Channel Blockers / pharmacology
  • Sulfonamides / pharmacology
  • Tetrodotoxin / pharmacology
  • Thiadiazoles / pharmacology
  • Xanthenes / pharmacology

Substances

  • Cholinergic Agonists
  • N-(3-oxo-3-(4-(pyridin-4-yl)piperazin-1-yl)propyl)benzo(c)(1,2,5)thiadiazole-4-sulfonamide
  • NAV1.9 Voltage-Gated Sodium Channel
  • Receptors, Muscarinic
  • Scn11a protein, rat
  • Sodium Channel Blockers
  • Sulfonamides
  • Thiadiazoles
  • Xanthenes
  • benzamil
  • Apamin
  • Tetrodotoxin
  • Amiloride
  • gallein
  • Carbachol